Guidance on issuing the Steroid Emergency Card in adults

David Erskine, Director, London Medicines Information Services, Specialist Pharmacy ServicePublished Last updated See all updates

The NHS England and NHS Improvement national patient safety alert (NatPSA) has specified a number of actions that organisations need to implement.

Non-SPS content · This content has not been generated nor formally reviewed by SPS

Non-SPS content is present where SPS believes that the content supports our end-users’ work, and is credible and trusted. Non-SPS content is posted in collaboration with the non-SPS author; however, it has not been generated nor formally reviewed by SPS

Summary 

The NHS England and Improvement national patient safety alert (NatPSA) has specified a number of actions that organisations need to implement.

  • To support implementation, the Society for Endocrinology, the Specialist Pharmacy Service (SPS), and the British Association of Dermatology (BAD) have produced more detailed guidance.
  • This can be used by primary and secondary care providers as necessary to implement the NatPSA in a more consistent way.

The guidance addresses the following clinical questions

  • Which patients are at risk of HPA axis suppression from exogenous steroids
  • Who should be issued with a Steroid Emergency Card and have sick day rules
  • Advice for intercurrent illness, procedures and surgery
  • Who should have steroid cover for procedures, surgery and acute intercurrent illness
  • Who requires adrenal function assessment

Further information

The link below may be disseminated as appropriate. Any queries from a pharmacy perspective please contact david.erskine@gstt.nhs.uk

Change history

  1. fixed broken link
  1. Published